Hemoglobin promotes Aβ oligomer formation and localizes in neurons and amyloid deposits

Neurobiology of Disease

Volumn 17, Issue 3, 2004, Pages 367-377

  Wu, Chih Wei ^a   Liao, Pao Chi ^a   Yu, Lung ^a   Wang, Shan Tair ^a   Chen, Shur Tzu ^a   Wu, Ching Ming ^a   Kuo, Yu Min ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Amyloid binding protein; Hemoglobin; Immunoprecipitation; Vascular pathology

Indexed keywords

AMYLOID BETA PROTEIN; HEMOGLOBIN; AMYLOID; PRIMER DNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; OLIGOMERIZATION; PARIETAL LOBE; PATHOGENESIS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENILE PLAQUE; VASCULAR AMYLOIDOSIS; WHITE MATTER; BRAIN; CHEMISTRY; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PROTEIN QUATERNARY STRUCTURE; REFERENCE VALUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; BRAIN; DNA PRIMERS; FEMALE; HEMOGLOBINS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; NEURONS; PROTEIN STRUCTURE, QUATERNARY; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 9644302450     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.08.014     Document Type: Article

References (49)

1. G.M. Bishop, S.R. Robinson, Q. Liu, G. Perry, C.S. Atwood, and M.A. Smith Iron: a pathological mediator of Alzheimer disease Dev. Neurosci. 24 2002 184 187
2. E.M. Blalock, K.C. Chen, K. Sharrow, J.P. Herman, N.M. Porter, T.C. Foster, and P.W. Landfield Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment J. Neurosci. 23 2003 3807 3819
3. F. Coria, E. Castano, F. Prelli, M. Larrondo-Lillo, S. van Duinen, M.L. Shelanski, and B. Frangione Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis Lab. Invest. 58 1988 454 458
4. P. Cutler, F. Brown, P. Camilleri, D. Carpenter, A. George, C. Gray, M. Haran, and B. Stewart The recognition of haemoglobin by antibodies raised for the immunoassay of beta-amyloid FEBS Lett. 412 1997 341 345
5. J.C. de la Torre Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease Ann. N. Y. Acad. Sci. 924 2000 136 152
6. J.C. de la Torre Alzheimer disease as a vascular disorder: nosological evidence Stroke 33 2002 1152 1162
7. S. Eriksson, S. Janciauskiene, and L. Lannfelt Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation Proc. Natl. Acad. Sci. U. S. A. 92 1995 2313 2317
8. K.C. Evans, E.P. Berger, C.G. Cho, K.H. Weisgraber, and P.T. Lansbury Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 92 1995 763 767
9. P.E. Fraser, J.T. Nguyen, D.R. McLachlan, C.R. Abraham, and D.A. Kirschner Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro J. Neurochem. 61 1993 298 305
10. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 120 1984 885 890
11. H. Hamazaki Amyloid P component promotes aggregation of Alzheimer's beta-amyloid peptide Biochem. Biophys. Res. Commun. 211 1995 349 353
12. D.M. Hartley, D.M. Walsh, C.P. Ye, T. Diehl, S. Vasquez, P.M. Vassilev, D.B. Teplow, and D.J. Selkoe Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons J. Neurosci. 19 1999 8876 8884
13. B.T. Hyman, and J.Q. Trojanowski Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease J. Neuropathol. Exp. Neurol. 56 1997 1095 1097
14. J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J. Lipid Res. 31 1990 545 548
15. S. Janciauskiene, P. Garcia de Frutos, E. Carlemalm, B. Dahlback, and S. Eriksson Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component J. Biol. Chem. 270 1995 26041 26044
16. K.A. Jellinger Vascular-ischemic dementia: an update J. Neural Transm., Suppl. 2002 1 23
17. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, R. Barbour, K. Khan, M. Gordon, H. Tan, D. Games, I. Lieberburg, D. Schenk, P. Seubert, and L. McConlogue Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 1550 1555
18. A.A. Karelin, M.M. Philippova, E.V. Karelina, and V.T. Ivanov Isolation of endogenous hemorphin-related hemoglobin fragments from bovine brain Biochem. Biophys. Res. Commun. 202 1994 410 415
19. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, and C.G. Glabe Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
20. E.H. Koo, S.S. Sisodia, L.C. Cork, A. Unterbeck, R.M Bayney, and D.L. Price Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer's disease and in aged nonhuman primates Neuron 4 1990 97 104
21. Y.M. Kuo, M.R. Emmerling, A.S. Woods, R.J. Cotter, and A.E. Roher Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits Biochem. Biophys. Res. Commun. 237 1997 188 191
22. H.A. Lashuel, D. Hartley, B.M. Petre, T. Walz, and P.T. Lansbury Jr. Neurodegenerative disease: amyloid pores from pathogenic mutations Nature 418 2002 291
23. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52
24. J. Ma, A. Yee, H.B. Brewer Jr., S. Das, and H. Potter Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments Nature 372 1994 92 94
25. P.W. Mantyh, J.R. Ghilardi, S. Rogers, E. DeMaster, C.J. Allen, E.R. Stimson, and J.E. Maggio Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide J. Neurochem. 61 1993 1171 1174
26. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonald, and K. Beyreuther Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U. S. A. 82 1985 4245 4249
27. E.D. Means, and D.K. Anderson Neuronophagia by leukocytes in experimental spinal cord injury J. Neuropathol. Exp. Neurol. 42 1983 707 719
28. F. Oyama, H. Shimada, R. Oyama, K. Titani, and Y. Ihara Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau J. Neuropathol. Exp. Neurol. 50 1991 560 578
29. F. Oyama, H. Shimada, R. Oyama, K. Titani, and Y. Ihara Beta-amyloid protein precursor and tau mRNA levels versus beta-amyloid plaque and neurofibrillary tangles in the aged human brain J. Neurochem. 60 1993 1658 1664
30. R. Oyama, H. Yamamoto, and K. Titani Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation Biochim. Biophys. Acta 1479 2000 91 102
31. S.S. Panter, S.M. Sadrzadeh, P.E. Hallaway, J.L. Haines, V.E. Anderson, and J.W. Eaton Hypohaptoglobinemia associated with familial epilepsy J. Exp. Med. 161 1985 748 754
32. J. Raymackers, A. Daniels, V. DeBrabandere, C. Missiaen, M. Dauwe, P. Verhaert, E. Vanmechelen, and L. Meheus Identification of two-dimensionally separated human cerebrospinal fluid proteins by N-terminal sequencing, matrix-assisted laser desorption/ionization-mass spectrometry, nanoliquid chromatography-electrospray ionization-time of flight-mass spectrometry, and tandem mass spectrometry Electrophoresis 21 2000 2266 2283
33. J. Rogers, N.R. Cooper, S. Webster, J. Schultz, P.L. McGeer, S.D. Styren, W.H. Civin, L. Brachova, B. Bradt, P. Ward, and I. Lieberburg Complement activation by beta-amyloid in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 89 1992 10016 10020
34. A.E. Roher, J.D. Lowenson, S. Clarke, C. Wolkow, R. Wang, R.J. Cotter, I.M. Reardon, H.A. Zurcher-Neely, R.L. Heinrikson, and M.J. Ball Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease J. Biol. Chem. 268 1993 3072 3083
35. C.A. Rottkamp, A.K. Raina, X. Zhu, E. Gaier, A.I. Bush, C.S. Atwood, M. Chevion, G. Perry, and M.A. Smith Redox-active iron mediates amyloid-beta toxicity Free Radical Biol. Med. 30 2001 447 450
36. S.M. Sadrzadeh, E. Graf, S.S. Panter, P.E. Hallaway, and J.W. Eaton Hemoglobin. A biologic Fenton reagent J. Biol. Chem. 259 1984 14354 14356
37. S.M. Sadrzadeh, D.K. Anderson, S.S. Panter, P.E. Hallaway, and J.W. Eaton Hemoglobin potentiates central nervous system damage J. Clin. Invest. 79 1987 662 664
38. D.A. Sanan, K.H. Weisgraber, S.J. Russell, R.W. Mahley, D. Huang, A. Saunders, D. Schmechel, T. Wisniewski, B. Frangione, A.D. Roses, and S.C. Rall Jr. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 J. Clin. Invest. 94 1994 860 869
39. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L. Faull, and G.J. Cooper Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process Proteomics 1 2001 1519 1528
40. A.L. Schwarzman, L. Gregori, M.P. Vitek, S. Lyubski, W.J. Strittmatter, J.J. Enghilde, R. Bhasin, J. Silverman, K.H. Weisgraber, P.K. Coyle, M.G. Zagorsri, J. Talafous, M. Eisenberg, A.M. Saunders, A.D. Roses, and D. Goldgaber Transthyretin sequesters amyloid beta protein and prevents amyloid formation Proc. Natl. Acad. Sci. U. S. A. 91 1994 8368 8372
41. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180
42. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal. Chem. 68 1996 850 858
43. J.R. Slemmon, C.M. Hughes, G.A. Campbell, and D.G. Flood Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum J. Neurosci. 14 1994 2225 2235
44. A.D. Snow, R. Sekiguchi, D. Nochlin, P. Fraser, K. Kimata, A. Mizutani, M. Arai, W.A. Schreier, and D.G. Morgan An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain Neuron 12 1994 219 234
45. M.D. Watson, A.E. Roher, K.S. Kim, K. Spiegel, and M. Emmerling Complement interactions with amyloid Abeta 1-42: a nidus for inflammation in AD brains Amyloid: Int. J. Exp. Clin. Invest. 4 1997 147 156
46. S. Webster, B. Bonnell, and J. Rogers Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide Am. J. Pathol. 150 1997 1531 1536
47. T. Wisniewski, E.M. Castano, A. Golabek, T. Vogel, and B. Frangione Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro Am. J. Pathol. 145 1994 1030 1035
48. B.V. Zlokovic, C.L. Martel, J.B. Mackic, E. Matsubara, T. Wisniewski, J.G. McComb, B. Frangione, and J. Ghiso Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta Biochem. Biophys. Res. Commun. 205 1994 1431 1437
49. B.V. Zlokovic, C.L. Martel, E. Matsubara, J.G. McComb, G. Zheng, R.T. McCluskey, B. Frangione, and J. Ghiso Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers Proc. Natl. Acad. Sci. U. S. A. 93 1996 4229 4234